High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis.
暂无分享,去创建一个
F. Gaita | A. Abbate | M. Mancone | F. D’Ascenzo | E. Cerrato | S. Gili | J. Escaned | U. Barbero | C. Moretti | P. Omede' | A. Calcagno | S. Veglia | D. Garabello | V. Estrada | S. Bonora | M. Cannillo | F. Ballocca | M. Pianelli | A. Montefusco | Alessio Raviola | Davide Salera | Elisa Mistretta | G. Zoccai | W. Grossomarra | Daniela De Marie | Sebastiano Gili | Simona Veglia
[1] O. Yang,et al. Hdl Redox Activity is Increased in HIV-Infected Men in Association with Macrophage Activation and Non-Calcified Coronary Atherosclerotic Plaque , 2014, Antiviral therapy.
[2] C. Nordeen. Associations Between HIV infection and Subclinical Coronary Atherosclerosis , 2014 .
[3] J. DiNicolantonio,et al. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. , 2014, Thrombosis research.
[4] P. Meikle,et al. Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease. , 2014, European heart journal cardiovascular Imaging.
[5] Richard D Moore,et al. Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] Jeroen J. Bax,et al. Prognostic value of aortic and mitral valve calcium detected by contrast cardiac computed tomography angiography in patients with suspicion of coronary artery disease. , 2014, The American journal of cardiology.
[7] Seung‐Jung Park,et al. Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus. , 2014, The American journal of cardiology.
[8] M. McCarter,et al. Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo , 2014, Retrovirology.
[9] G. d’Ettorre,et al. Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin , 2013, ISRN AIDS.
[10] F. Madeo,et al. Cell death pathways. , 2013, Biochimica et biophysica acta.
[11] M. J. Kasten,et al. Human immunodeficiency virus: what primary care clinicians need to know. , 2013, Mayo Clinic proceedings.
[12] G. Raff,et al. Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. , 2013, European heart journal cardiovascular Imaging.
[13] S. Abbara,et al. Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men , 2013, AIDS.
[14] F. Gaita,et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. , 2013, European heart journal.
[15] K. Dabhadkar,et al. Polypill strategy for primary prevention of cardiovascular disorders. , 2013, Drugs of today.
[16] J. Mallolas,et al. Differences between HIV‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies , 2013, HIV medicine.
[17] F. Gaita,et al. Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. , 2013, Atherosclerosis.
[18] A. Westfall,et al. Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] F. Pereyra,et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers , 2012, AIDS.
[20] Matthias F Kriegel,et al. Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. , 2012, Radiology.
[21] S. Abbara,et al. Receptor Activator of Nuclear Factor-&kgr;B Ligand (RANKL) and Its Relationship to Coronary Atherosclerosis in HIV Patients , 2012, Journal of acquired immune deficiency syndromes.
[22] Jeffrey N. Martin,et al. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis , 2012, AIDS.
[23] F. Gaita,et al. Coronary artery disease Acute coronary syndromes in human immunodeficiency virus patients : a meta-analysis investigating adverse event rates and the role of antiretroviral therapy , 2012 .
[24] H. Masur,et al. Non-Calcified Coronary Plaque Volume Inversely Related to Cd4+ T-Cell Count in HIV Infection , 2011, Antiviral therapy.
[25] E. Rosenberg,et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. , 2011, The Journal of infectious diseases.
[26] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[27] M. Budoff,et al. Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. , 2011, The American journal of cardiology.
[28] E. Rosenberg,et al. Soluble CD 163 , a Novel Marker of Activated Macrophages , Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected Patients , 2011 .
[29] S. Abbara,et al. Increased Coronary Artery Calcium Score and Noncalcified Plaque Among HIV-Infected Men: Relationship to Metabolic Syndrome and Cardiac Risk Parameters , 2010, Journal of acquired immune deficiency syndromes.
[30] S. Abbara,et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men , 2010, AIDS.
[31] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[32] R. Kronmal,et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study , 2009, AIDS.
[33] A. Sharrett,et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men , 2008, AIDS.
[34] Moyses Szklo,et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.
[35] S. Abbara. Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups , 2008 .
[36] Hirofumi Anno,et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. , 2007, Journal of the American College of Cardiology.
[37] W. K. Henry,et al. Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults , 2007, AIDS.
[38] Renu Virmani,et al. Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.
[39] M. Hadamitzky,et al. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. , 2006, Journal of the American College of Cardiology.
[40] Jeffrey N. Martin,et al. Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection , 2004, Circulation.
[41] Katherine C. Wu,et al. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. , 2002, American heart journal.
[42] R. Talwani,et al. Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. , 2002, Journal of acquired immune deficiency syndromes.
[43] J. Ornato,et al. Acute coronary syndromes , 2002 .
[44] I. Olkin,et al. Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement , 2000, Revista espanola de salud publica.
[45] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[46] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[47] The Progression of Atherosclerosis , 1985, The Lancet.